CTRLHi D1Lo D1Hi D1 + AZTHLo D5PrEPMF 1
MF 2
MF 3
MF 4MF 5
MF 6
MF 7
MF 8MF 9
MF 10
MF 11
MF 12
MF 13MF 14
MF 15
MF16
MF17MF18
MF19
MF20
MF21
MF22MF23
MF24
MF25
MF26MF27
MF28
MF29
MF30
MF31WBC LymphocytesNeutrophils Monocytes05152010-8-4 02 4281216 0 42805152010-8-4 02 4281216 0 42805152010-8-4 02 4281216 0 42805152010-8-4 02 4281216 0 42805152010-8-4 02 4281216 0 42805152010-8-4 02 4281216 0 4280105-8-4 02 4281216 0 4280105-8-4 02 4281216 0 4280105-8-4 02 42812160 4280105-8-4 02 4281216 0 4280105-8-4 02 4281216 0 4280105-8-4 02 42812160 428051510-8-4 02 42812160 428051510-8-4 02 42812160 428051510-8-4 02 4281216 0 428051510-8-4 02 4281216 0 428051510-8-4 02 4281216 0 428051510-8-4 02 4281216 0 4280.00.51.54.01.0-8-4 024281216 0 4283.00.00.51.54.01.0-8-4 024281216 0 4283.00.00.51.54.01.0-8-4 024281216 0 4283.00.00.51.54.01.0-8-4 024281216 0 4283.00.00.51.54.01.0-8-4 024281216 0 4283.00.00.51.54.01.0-8-4 024281216 0 4283.0Days post infectionx 103 cells / μLabcdExtended Data Fig. 5 | Complete blood count of SARS-CoV-2-infected
cynomolgus macaques treated with HCQ. a–d, Absolute numbers of white
blood cells (WBC) (a), lymphocytes (b), neutrophils (c) and monocytes (d) in
SARS-CoV-2-infected macaques. Baseline was adjusted to day 0 on the graphs,
and to the first day of treatment (day 7 pre-exposure) for the PrEP group.
Shaded zones indicate treatment periods.